Hematological Malignancies
📧 Sign up to get email alerts when something new happens for Hematological Malignancies.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-22Clinical Trial Results: Expanded Access of Omidubicel, for Allogeneic Transplantation in Patients With Hematological Malignancies [Phase 3]
Phase 3 expanded access trial results for omidubicel in allogeneic transplantation for hematological malignancies have been completed with p…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Feasibility of the Use of Weighted Blankets to Improve Sleep Among Patients With Hematological Malignancies [NA]
This clinical trial update assesses the feasibility of using weighted blankets to improve sleep among patients with hematological malignanci…
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Kinectics of Donor-specific Anti-HLA Antibody After HLA-incompatible Allogeneic Haematopoietic Stem Cell Transplantation
This clinical trial update examines the kinetics of donor-specific anti-HLA antibodies after HLA-incompatible allogeneic hematopoietic stem …
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related Donors [Phase 2]
Phase 2 trial update on allogeneic hematopoietic stem cell transplantation from unrelated or partially matched related donors for hematologi…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Optimizing GVHD Prophylaxis After Allogeneic Hematopoietic Cell Transplantation [Phase 2]
Phase 2 clinical trial registration to optimize graft-versus-host disease prophylaxis after allogeneic hematopoietic cell transplantation. T…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Micro Assays for HemATology Malignancies Antibody Treatment [NA]
A clinical trial update about a micro assays-based antibody treatment for hematological malignancies. The study status is not yet recruiting…
-
CLINICAL_TRIALS other · 2025-09-29Clinical Trial Update: A Clinical Study of HMPL-506 in Patients With Hematological Malignancies [Phase 1]
Phase 1 clinical study of HMPL-506 in patients with hematological malignancies is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis [NA]
A completed clinical trial evaluating hepatosplenic candidiasis using PET scans and immune response analysis in patients with invasive candi…
-
CLINICAL_TRIALS research · 2025-07-15Clinical Trial Update: Investigation of the Effects of Prehabilitation Education Delivered Through a Mobile Compatible Website on Quality of Life and Symptoms in Patients Undergoing Hematopoietic Stem Cell Transplantation [NA]
This clinical trial update reports on a study evaluating prehabilitation education delivered via a mobile-compatible website to improve qual…
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: Safety, Tolerability and Pharmacokinetics Study of KPG-818 in Hematological Malignancies Subjects [Phase 1]
A completed Phase 1 study assessing safety, tolerability and pharmacokinetics of KPG-818 in patients with hematological malignancies.
-
CLINICAL_TRIALS research · 2025-03-17Clinical Trial Update: APA and Relaxation by Biofeedback in Patients With Haematological Malignancy Admitted in ICU [NA]
A clinical trial is recruiting to test adapted physical activity and biofeedback-based relaxation in ICU patients with hematological maligna…
-
CLINICAL_TRIALS withdrawal · 2024-10-03Clinical Trial Update: B-Cell Hematologic Malignancy Vaccination Registry
A clinical trial update indicates that the B-cell hematologic malignancy vaccination registry (NCT02298816) sponsored by Wake Forest Univers…
-
CLINICAL_TRIALS trial_result · 2024-07-18Clinical Trial Update: A Study of ATG-018 (ATR Inhibitor) Treatment in Patients With Advanced Solid Tumors and Hematological Malignancies [Phase 1]
Phase 1 study of ATG-018, an ATR inhibitor, in patients with advanced solid tumors and hematological malignancies has been terminated.
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis Regimens [Phase 2]
Phase 2 clinical trial update comparing two graft-versus-host disease prophylaxis regimens in minitransplants with HLA-matched donors for he…
-
CLINICAL_TRIALS trial_result · 2023-12-18Clinical Trial Update: Allogeneic Immunotherapy for Hematological Malignancies by Selective Depletion of Regulatory T Cells [Phase 3]
Phase 3 trial update on allogeneic immunotherapy for hematological malignancies focusing on selective depletion of regulatory T cells.
-
CLINICAL_TRIALS trial_result · 2023-11-03Clinical Trial Update: Dose-range Finding Treosulfan-based Conditioning [Phase 1, Phase 2]
A dose-range finding study of treosulfan-based conditioning for hematological malignancies completed Phase 1/2.
-
CLINICAL_TRIALS trial_result · 2022-12-21Clinical Trial Update: CMV Specific T Cell Therapy After Allogeneic Stem Cell Transplantation. [Phase 2]
Phase 2 trial evaluating CMV-specific T cell therapy after allogeneic stem cell transplantation in hematologic malignancies with CMV infecti…
-
CLINICAL_TRIALS trial_result · 2022-11-10Clinical Trial Update: Switched Memory B-cells as a Marker for Humoral Immune System Recovery in Patients With Secondary Antibody Deficiency Due to Hematological Malignancies [Phase 4]
Phase 4 trial investigating switched memory B-cells as a marker for humoral immune system recovery in patients with secondary antibody defic…
-
CLINICAL_TRIALS trial_result · 2022-07-21Clinical Trial Update: Infusion of Depleted T Cells Following Unrelated Donor Stem Cell Transplant (ICAT) [Phase 1, Phase 2]
Phase 1/2 trial assessing infusion of depleted T cells after unrelated donor stem cell transplant for hematological malignancies has complet…
-
CLINICAL_TRIALS trial_result · 2022-07-19Clinical Trial Update: PRevention Of BLeeding in hEmatological Malignancies With Antifibrinolytic (Epsilon Aminocaproic Acid) [Phase 2]
Phase 2 trial evaluating epsilon-aminocaproic acid to prevent bleeding in patients with hematological malignancies and thrombocytopenia; stu…
-
CLINICAL_TRIALS trial_result · 2022-01-26Clinical Trial Update: Allogeneic HCT With HLA-matched Donors : a Phase II Randomized Study Comparing 2 Nonmyeloablative Conditionings [Phase 2]
Phase II randomized trial comparing two nonmyeloablative conditioning regimens for allogeneic hematopoietic cell transplantation from HLA-ma…
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: MiHA-loaded PD-L-silenced DC Vaccination After Allogeneic SCT [Phase 1, Phase 2]
Phase 1/2 trial evaluating MiHA-loaded PD-L-silenced dendritic cell vaccination after allogeneic stem cell transplantation in hematological …
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer [Phase 1]
Phase 1 safety study of KPT-330 (selective inhibitor of nuclear export) in advanced hematological cancers completed; results available.
-
CLINICAL_TRIALS trial_result · 2021-03-19Clinical Trial Update: Intrabone Infusion of Cord Blood in Adults With Hematological Malignancies [Phase 2]
Phase 2 clinical trial update evaluating intrabone infusion of cord blood in adults with hematological malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2021-03-10Clinical Trial Update: Sequential Radiotherapy With CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies With Extramedullary Lesions [Phase 1, Phase 2]
Phase 1/2 trial evaluating sequential radiotherapy combined with CAR-T cells for relapsed/refractory hematological malignancies with extrame…